Emoclot 500iu/10ml Human Plasma Coagulation Factor VIII Infusion In Pakistan

Emoclot 500iu/10ml Human Plasma Coagulation Factor VIII Infusion In Pakistan

• Brand Name : Emoclot 500iu/10ml
• Composition : Human Plasma Coagulation Factor VIII
• Manufactured By : Kedrion Biopharma
• Form : Infusion
• Packing : 10 ml
• Country Of Origin : Italy

Emoclot 500 IU/10 ml Human Plasma Coagulation Factor VIII Infusion in Pakistan

Emoclot 500 IU/10 ml is a human plasma-derived coagulation Factor VIII medicine used to help control and prevent bleeding associated with Factor VIII deficiency. It is supplied as a powder with a solvent for preparation of an intravenous infusion. The product is manufactured by Kedrion S.p.A., Italy.

Active Ingredient

• Human Plasma Coagulation Factor VIII
• Strength: 500 IU per vial
• Reconstituted concentration: 50 IU/ml (500 IU/10 ml)
• Pharmaceutical form: Powder and solvent for solution for infusion.

Uses & Indications

Emoclot may be prescribed for:

• Treatment and prevention of bleeding in patients with Hemophilia A caused by inherited Factor VIII deficiency.
• Treatment of bleeding associated with an acquired Factor VIII deficiency.
• Certain cases involving Hemophilia A patients who have developed Factor VIII inhibitors, under specialist medical supervision.

How Emoclot Works

Factor VIII is an essential protein involved in the body's blood-clotting process. Replacing deficient Factor VIII helps restore the coagulation process and supports the formation of stable blood clots.

Pack & Composition

The 500 IU presentation contains a vial of lyophilized Factor VIII powder and a 10 ml vial of Water for Injection as the solvent. The formulation also contains excipients including sodium chloride, sodium citrate, glycine and calcium chloride.

Administration

Emoclot is administered intravenously after reconstitution. The required dose and frequency depend on the patient's Factor VIII level, the type and severity of bleeding, body weight, and the clinical situation. It should be prepared and administered by appropriately trained healthcare professionals.

Storage

Factor VIII plasma products generally require controlled refrigerated storage. Product information for Emoclot lists storage at 2°C–8°C. Do not freeze, and follow the storage conditions stated on the product packaging and official leaflet.

Availability in Pakistan

Emoclot 500 IU/10 ml may be available through specialized pharmaceutical suppliers and hospital/hematology channels in Pakistan. Availability can vary, so patients should verify the product's batch number, expiry date, packaging and storage conditions before purchase.

Important Safety Information

Emoclot is a prescription medicine and should only be used under the supervision of a qualified physician, particularly a hematologist. Allergic or hypersensitivity reactions can occur, and patients receiving Factor VIII may develop inhibitors that reduce treatment effectiveness. Seek immediate medical attention for signs of a serious allergic reaction or unexpected bleeding.

Note: This information is for general product education and is not a substitute for the prescribing doctor's instructions.